Founder, M.H. Carnegie & Co
Every published round Mark Carnegie took part in, and every parcel of existing shares it bought off another holder. Deals we hold but haven't published yet are not counted.
Companies Mark Carnegie has backed in a published round, and companies whose existing shares it bought off another holder.
| Company | What it does | First invested | Rounds | Led |
|---|---|---|---|---|
| No portfolio companies recorded yet. | ||||
Fund closes reported for Mark Carnegie, as distinct from the investments it has made.
Companies Mark Carnegie has backed that another company then bought. An exit for the holding, not a deal Mark Carnegie did.
Stories naming Mark Carnegie. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.
Qantas Super has committed A$75 million to For Purpose Investment Partners' aged care platform, with Australian Ethical adding an initial $10 million, enabling FP Aged Care Australia to expand its facility portfolio.
Techboard's monthly roundup cataloguing April 2022 Australian startup funding: megadeals, seed rounds, grants and crowdfunding, nine acquisitions, several ASX listings, and venture firms' fund news.
US-based leadless pacemaker maker EBR Systems has listed on the ASX, spurning US SPAC offers thanks to its local investor base; Blackbird's earlier investment in Vexev is also noted.
Also Brandon Capital portfolio·Brandon Capital portfolio·Brandon BioCatalyst portfolio